Hals PA - Search Results

1

In vivo cleavage rate of a dextran-bound magnetic resonance imaging contrast agent: preparation and intravascular pharmacokinetic characteristics in the rabbit.

Hals PA, Sontum PC, Holtz E, Klaveness J, Rongved P. Hals PA, et al. Curr Drug Deliv. 2013 Feb;10(1):134-43. doi: 10.2174/1567201811310010019. Curr Drug Deliv. 2013. PMID: 22452401

2

Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.

Harpur ES, Worah D, Hals PA, Holtz E, Furuhama K, Nomura H. Harpur ES, et al. Among authors: hals pa. Invest Radiol. 1993 Mar;28 Suppl 1:S28-43. doi: 10.1097/00004424-199303001-00004. Invest Radiol. 1993. PMID: 8486501 Review.

3

In vivo stability and excretion of gadodiamide (GdDTPA-BMA), a hydrophilic gadolinium complex used as a contrast enhancing agent for magnetic resonance imaging.

Normann PT, Hals PA. Normann PT, et al. Among authors: hals pa. Eur J Drug Metab Pharmacokinet. 1995 Oct-Dec;20(4):307-13. doi: 10.1007/BF03190250. Eur J Drug Metab Pharmacokinet. 1995. PMID: 8983938

4

Biodistribution and toxicity of MR imaging contrast media.

Oksendal AN, Hals PA. Oksendal AN, et al. Among authors: hals pa. J Magn Reson Imaging. 1993 Jan-Feb;3(1):157-65. doi: 10.1002/jmri.1880030128. J Magn Reson Imaging. 1993. PMID: 8428083 Review. No abstract available.

5

Human pharmacokinetics of iodixanol.

Svaland MG, Haider T, Langseth-Manrique K, Andrew E, Hals PA. Svaland MG, et al. Among authors: hals pa. Invest Radiol. 1992 Feb;27(2):130-3. doi: 10.1097/00004424-199202000-00007. Invest Radiol. 1992. PMID: 1601604

6

A respiration-metabolism chamber system and a GC-MS method developed for studying exhalation of perfluorobutane in rats after intravenous injection of the ultrasound contrast agent Sonazoid.

Uran S, Landmark K, Normann PT, Hals PA, Toft KG, Skotland T. Uran S, et al. Among authors: hals pa. J Pharm Biomed Anal. 2005 Sep 15;39(3-4):746-51. doi: 10.1016/j.jpba.2005.04.038. J Pharm Biomed Anal. 2005. PMID: 15964732

7

Disposition of perfluorobutane in rats after intravenous injection of Sonazoid.

Toft KG, Hustvedt SO, Hals PA, Oulie I, Uran S, Landmark K, Normann PT, Skotland T. Toft KG, et al. Among authors: hals pa. Ultrasound Med Biol. 2006 Jan;32(1):107-14. doi: 10.1016/j.ultrasmedbio.2005.09.008. Ultrasound Med Biol. 2006. PMID: 16364802

8

Elacytarabine in relapsed/refractory acute myeloid leukaemia: an evaluation of clinical efficacy, pharmacokinetics, cardiac safety and effects on lipid profile.

Knapper S, Chevassut T, Duarte R, Bergua JM, Salamero O, Johansen M, Jacobsen TF, Hals PA, Rasch W, Gianella-Borradori A, Smith M. Knapper S, et al. Among authors: hals pa. Leuk Res. 2014 Mar;38(3):346-51. doi: 10.1016/j.leukres.2013.12.011. Epub 2013 Dec 25. Leuk Res. 2014. PMID: 24433865 Clinical Trial.

9

Metabolism of levomepromazine in man.

Hals PA, Dahl SG. Hals PA, et al. Eur J Drug Metab Pharmacokinet. 1995 Jan-Mar;20(1):61-71. doi: 10.1007/BF03192290. Eur J Drug Metab Pharmacokinet. 1995. PMID: 7588996

10

Negative gastrointestinal contrast enhancement and image distortion induced by superparamagnetic particles at 0.02 Tesla.

Niemi P, Paajanen H, Hals PA, Tertti M, Komu M, Kormano M. Niemi P, et al. Among authors: hals pa. Magn Reson Imaging. 1989 Nov-Dec;7(6):649-53. doi: 10.1016/0730-725x(89)90534-1. Magn Reson Imaging. 1989. PMID: 2630848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page